CODX - Co-Diagnostics Inc

Momentum: Bearish

Recent News

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

GlobeNewswire • 4 months ago • score: 0.02

Salt Lake City, Utah, May 14, 2025 ( GLOBE NEWSWIRE ) -- Co-Diagnostics, Inc. ( Nasdaq: CODX ) ( the "Company" or "Co-Dx" ) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that they will be participating in the ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.

52W High

$1.40

52W Low

$0.23

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.79

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

16.00

EV/EBITDA (<8 favorable)

0.52

EV/Revenue (<3 favorable)

0.28

P/S (TTM) (<3 favorable)

11.89

P/B (<3 favorable)

0.29

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

7.88%

Institutions (25–75% balanced)

13.46%

Shares Outstanding

38,523,600

Float

35,890,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

1,003,700

Gross Profit (TTM)

397,490

EPS (TTM)

-1.15

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-49.46%

ROE (TTM) (>15% strong)

-0.63%

EPS YoY (Quarterly) (>10% good)

0.31

Revenue YoY (Quarterly) (>8% good)

-0.94

Momentum

Bearish momentum

Value

0.0150

0.0135

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025